Cargando…
Soluble Guanylate Cyclase Activators to Treat Benign Prostatic Hyperplasia and associated LUTS
This review summarises the presentations during a workshop session entitled “The Use of Soluble Guanylate Cyclase Activators to Treat Benign Prostatic Hyperplasia, Obstruction and Fibrosis – Mechanistic Concepts and Clinical Implications” at the International Continence Society (ICS) 2021 Melbourne...
Autores principales: | Kanai, A.J., Andersson, K.-E., Birder, L.A., Fry, C.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310070/ https://www.ncbi.nlm.nih.gov/pubmed/37389026 http://dx.doi.org/10.1016/j.cont.2023.100699 |
Ejemplares similares
-
Structural studies of soluble guanylate cyclase
por: Macdonald, Jane, et al.
Publicado: (2009) -
Structural Perspectives on the Mechanism of Soluble Guanylate Cyclase Activation
por: Wittenborn, Elizabeth C., et al.
Publicado: (2021) -
Soluble Guanylate Cyclase Stimulators in Heart Failure
por: Kansakar, Sajog, et al.
Publicado: (2021) -
Activation mechanism of human soluble guanylate cyclase by stimulators and activators
por: Liu, Rui, et al.
Publicado: (2021) -
The discovery and characterization of novel soluble guanylate cyclase stimulators
por: Masferrer, Jaime L
Publicado: (2015)